The transaction is valued at ₹797 crore, subject to closing adjustments. As per the terms of the agreement, 50% of the sale consideration will be paid on the Closing Date, as defined in the BTA, while the remaining amount will be payable within 150 days from the Closing Date. Shares of Mankind Pharma Ltd ended at ₹2,464.00, down by ₹15.40, or 0.62%, on the BSE.
